Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06605807 · ClinicalTrials.gov registry record · NA

Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions

A NA study of Hypertension and Diabetes, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06605807: Recruiting NA study of Hypertension and Diabetes, sponsored by University of Pittsburgh.

NCT06605807 is a NA study of Hypertension and Diabetes that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 150 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06605807, a NA study of Hypertension and Diabetes, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot clinical trial is to learn if providing a clinical decision framework for managing older adults chronic conditions during hospitalization to inpatient clinicians improves clinicians' ability to individualize chronic condition prescribing decisions for hospitalized older adults (65 and older). The main questions it aims to answer are: * Will the clinical decision framework lead to clinicians having greater confidence to individualize discharge prescribing? * Will clinicians using the framework discharge make fewer changes to hospitalized older adults with home diabetes and hypertension medications than they did prior to receiving the framework? * Will older adult patients of participating clinicians will report fewer gaps in understanding of medication changes after the clinician is exposed to the framework? Researchers will compare participating clinician survey responses and prescribing records from before and after an educational session presenting the clinical decision framework. Participants will be asked to * Attend a one-time educational session on the clinical decision framework * Complete 2 electronic surveys, one before and one following the educational session. * Agree for researchers to contact their patients, in order for patients to complete a one-time phone survey about changes made to home medications during hospitalization and quality of communication from the hospital team.

Primary Outcome

For each clinician participant the investigators will ask their self-efficacy to individualize blood pressure and diabetes treatment decisions for hospitalized older adults. Measured through ten 7-point Likert scale questions measured \[Strongly Disagree - Strongly Agree\]. Scores will be summed and range from 10 (all Strongly Disagree) to 70 (all Strongly Agree).

Interventions

  • OTHER Clinical Decision Framework for Managing older adults' chronic conditions during hospitalization.

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-11-13
Est. Completion 2027-01-30
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06605807 shows while recruiting

NCT06605807 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower).

The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Clinical Decision Framework for Managing older adults' chronic conditions during hospitalization. is the first listed.

NCT06605807 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06605807 about?

NCT06605807 is a clinical study titled "Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions". The goal of this pilot clinical trial is to learn if providing a clinical decision framework for managing older adults chronic conditions during hospitalization to inpatient clinicians improves clinicians' ability to individualize chronic condition prescribing decisions for hospitalized older adults...

What is the current status of trial NCT06605807?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-11-13. Estimated completion is 2027-01-30.

What conditions does trial NCT06605807 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Multimorbidity, Geriatrics, Prescribing Decisions.

What interventions are being tested in trial NCT06605807?

The interventions under investigation include: Clinical Decision Framework for Managing older adults' chronic conditions during hospitalization. (OTHER).

Who is sponsoring clinical trial NCT06605807?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06605807 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06605807's enrollment target sits among peer trials

150 247th of 470 higher than 217 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06605807, the US trial registry maintained by the National Library of Medicine. NCT06605807 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.